Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Ac-Ala-Asn-Trp-AMC
65
CHF
CHF 65.00
In stock
AG-CP3-0037-M0011 mgCHF 65.00
AG-CP3-0037-M0055 mgCHF 130.00
AG-CP3-0037-M02525 mgCHF 520.00
Product Details | |
---|---|
Synonyms | Ac-ANW-AMC; Immunoproteasome Substrate |
Product Type | Chemical |
Properties | |
Formula |
C30H32N6O7 |
MW | 588.6 |
Sequence |
Acetyl-Ala-Asn-Trp-7-amido-4-methylcoumarin |
Purity Chemicals | ≥97% |
Appearance | Lyophilized powder. |
Solubility | Soluble in DMSO. |
Identity | Determined by MS. |
Other Product Data |
Peptide Content: ≥94% Use: After preparing a stock solution in DMSO (≥10mM) store product at -20°C to -80°C. It is recommended to make multiple aliquots after the first thaw to ensure best performance. Chymotrypsin-like activity can be measured using a typical working concentration range from 10-50µM. |
InChi Key | ORTKHFLJSJQDKO-ZCWWJEROSA-N |
Smiles | O=C([C@@H](NC(C)=O)C)N[C@@H](CC(N)=O)C(N[C@@H](CC1=CNC2=C1C=CC=C2) C(NC3=CC=C(C(C)=CC(O4)=O)C4=C3)=O)=O |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice |
Avoid freeze/thaw cycles. Protect from light. |
Use/Stability | Stable for at least 1 year after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Ac-ANW-AMC is a fluorogenic peptide substrate for measuring chymotrypsin-like activity of the immunoproteasome.
- Hydrolysis of this substrate by the β5i-subunit of the immunoproteasome is monitored by observing fluorescence at an Excitation wavelength of 345nm and Emission at 445nm.
- This substrate is specific to the immunoproteasome and is not hydrolyzed efficiently by the constitutive proteasome.
Product References
- Elucidating the catalytic subunit composition of distinct proteasome subtypes: A crosslinking approach employing bifunctional activity-based probes: C.K. Cornish, et al.; ChemBioChem 16, 284 (2015)
- Pharmacodynamic monitoring of (immuno) proteasome inhibition during bortezomib treatment of a critically ill patient with lupus nephritis and myocarditis: K.A. De Groot, et al.; Lupus Sci. Med. 2, e000121 (2015)
- Immunoproteasome β5i-selective dipeptidomimetic inhibitors: P.K. Singh, et al.; ChemMedChem 11, 2127 (2016)
- Acetaldehyde suppresses the display of HBV-MHC class I complexes on HBV-expressing hepatocytes: M. Ganesan, et al.; Am. J. Physiol. Gastrointest. Liver Physiol. 317, G127 (2019)
- Monitoring the immunoproteasome in live cells using an activity-based peptide–peptoid hybrid probe: B.L. Zerfas & D.J. Trader; J. Am. Chem. Soc. 141, 5252 (2019)
- Evaluation of Immunoproteasome-Specific Proteolytic Activity Using Fluorogenic Peptide Substrates: S. Kim, et al.; Immune Netw. 22, e23 (2022)